Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Sponsored by SpyGlass Pharma, Inc.
About this study
This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Where this study is enrolling
- I'm interested
Houston Eye Associates
Houston, Texas
Who can participate
Inclusion criteria
- ✓Diagnosis of mild to moderate open-angle glaucoma or ocular hypertension
- ✓Planned removal of cataract
- ✓Female participants of childbearing potential must have a negative urine pregnancy test at the baseline visit and agree to the use of contraception
Exclusion criteria
- ✕Uncontrolled systemic disease
- ✕History of incisional/refractive corneal surgery
- ✕Any glaucoma diagnosis other than OHT, open-angle, pseudoexfoliative, or pigmentary glaucoma
- ✕History of incisional glaucoma surgery or intraocular injections
- ✕Other ocular diseases, pathology, or conditions
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.